Skip to content
No results
  • About Us
    • Who We Are
    • Our Lab
  • What We Do
    • Focus Areas
    • Products & Services
    • Service Groups
  • Contact Us
  • News and Blogs
    • News
    • Blog
BOOK APPOINTMENT

Copyright © 2024 - Designed & Maintained By Nusite IT Management Consultants

Revnabio
  • About Us
    • Who We Are
    • Our Lab
  • What We Do
    • Focus Areas
    • Products & Services
    • Service Groups
  • Contact Us
  • News and Blogs
    • News
    • Blog
BOOK APPOINTMENT
Revnabio

What Is Precision Medicine and Why It Matters Today

Introduction Traditional medicine’s one-size-fits-all approach is giving way to precision medicine, a modern strategy that tailors care based…

Read MoreWhat Is Precision Medicine and Why It Matters Today

Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana  

Accra, Ghana – July 2025   The strategic partnership between AstraZeneca and Revna Biosciences is rapidly transforming the landscape…

Read MoreAccelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in Ghana  

Revna Biosciences Named to Bloomberg’s Africa Startups to Watch 2025 

Revna Biosciences is honored to announce that we’ve been recognized on Bloomberg’s inaugural “Africa Startups to Watch 2025”…

Read MoreRevna Biosciences Named to Bloomberg’s Africa Startups to Watch 2025 

AstraZeneca Partners with Revna Biosciences to Enhance EGFR Biomarker Testing in Ghana 

  AstraZeneca, a global biopharmaceutical company is in collaboration with Revna Biosciences, a precision medicine research and advanced…

Read MoreAstraZeneca Partners with Revna Biosciences to Enhance EGFR Biomarker Testing in Ghana 
Book Kidney function test (kft)

Book Kidney Function Test (KFT) in Ghana

Maintaining optimal kidney health is crucial for overall well-being. The kidneys play a vital role in filtering waste…

Read MoreBook Kidney Function Test (KFT) in Ghana

Revna Biosciences receives historic Food and Drugs Authority (FDA) approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa

The FDA approval secures RevnaBio as the first biomedical company to register/deploy the NeuMoDx platform in Sub-Saharan Africa,…

Read MoreRevna Biosciences receives historic Food and Drugs Authority (FDA) approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa
1 2 3
Next
No results

Archives

  • September 2025
  • July 2025
  • May 2025
  • April 2025
  • August 2023
  • June 2023
  • November 2022
This image has an empty alt attribute; its file name is Revna-Logo-white-01.svg

ghanaflag 5 Nii Kwei Okang Mensah Street, Nmai Dzorn, Accra Digital Address: GD-171-2679.

300 Welsh Road, Bldg One, Suite 100, PMB55 Horsham, PA 19044

Telephone: 0599009977 / 0599009989 / 0302523917
WhatsApp: 0599009977 / 0599009989
Email: info@revnabio.com

Quick Links
  • Who we are
  • Focus Areas
  • Products and Services
  • Service Groups
  • Our Lab
Get Exclusive Insights